Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 192.00
0.00 (0.00%)
Sep 1, 2026, 4:08 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 15.11 billion as of September 1, 2026.
Market Cap
15.11B
Enterprise Value
13.83B
Revenue
685.64M
Ranking
n/a
PE Ratio
83.18
Stock Price
192.00
ChartMarket Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 15.11B, an increase of 84.26%. That is a compound annual growth rate of 102.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 15.11B | 41.18% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 29.02B |
| China Resources Pharmaceutical Group | 28.71B |
| China Medical System Holdings | 27.40B |
| Sunshine Lake Pharma | 22.47B |
| Grand Pharmaceutical Group | 18.35B |
| The United Laboratories International Holdings | 16.84B |
| CanSino Biologics | 15.26B |
| Consun Pharmaceutical Group | 11.86B |